Lv0
0 积分 2024-11-21 加入
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
8天前
已完结
Tozorakimab to Prevent COPD Exacerbations
8天前
已完结
慢性阻塞性肺疾病相关性肺动脉高压患者外周血单核细胞Rho激酶水平测定
10天前
已完结
Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease
11天前
已完结
Neutrophil-to-lymphocyte ratio as an independent inflammatory indicator of poor prognosis in IgA nephropathy
1个月前
已完结
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
1个月前
已完结
[Clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)]
1个月前
已完结
Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA1 antagonism: exploratory analysis from a phase 2 trial of admilparant
2个月前
已完结
Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial
3个月前
已完结
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy
3个月前
已完结
皖公网安备34019202002308
